News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,646 Results
Type
Article (13946)
Company Profile (21)
Press Release (247672)
Multimedia
Podcasts (15)
Webinars (8)
Section
Business (73359)
Career Advice (535)
Deals (12153)
Drug Delivery (37)
Drug Development (47039)
Employer Resources (58)
FDA (6228)
Job Trends (5542)
News (136539)
Policy (11225)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1101)
Accelerated approval (15)
Adcomms (12)
Allergies (79)
Alliances (17413)
ALS (91)
Alzheimer's disease (812)
Antibody-drug conjugate (ADC) (189)
Approvals (6484)
Artificial intelligence (160)
Autoimmune disease (107)
Automation (6)
Bankruptcy (83)
Best Places to Work (4801)
BIOSECURE Act (10)
Biosimilars (88)
Biotechnology (27)
Bladder cancer (100)
Brain cancer (27)
Breast cancer (336)
Cancer (2922)
Cardiovascular disease (163)
Career advice (465)
Career pathing (9)
CAR-T (149)
CDC (3)
Cell therapy (356)
Cervical cancer (15)
Clinical research (41020)
Collaboration (763)
Company closure (1)
Compensation (254)
Complete response letters (28)
COVID-19 (1082)
CRISPR (40)
C-suite (280)
Cystic fibrosis (57)
Data (4048)
Denatured (4)
Depression (84)
Diabetes (229)
Diagnostics (1883)
Digital health (18)
Diversity (3)
Diversity, equity & inclusion (10)
Drug discovery (109)
Drug pricing (28)
Drug shortages (12)
Duchenne muscular dystrophy (103)
Earnings (38004)
Editorial (15)
Employer branding (6)
Employer resources (43)
Events (35729)
Executive appointments (323)
FDA (7983)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (636)
Gene editing (90)
Generative AI (13)
Gene therapy (216)
GLP-1 (531)
Government (1670)
Grass and pollen (2)
Guidances (303)
Healthcare (7244)
HIV (29)
Huntington's disease (16)
IgA nephropathy (58)
Immunology and inflammation (148)
Immuno-oncology (32)
Indications (61)
Infectious disease (1188)
Inflammatory bowel disease (129)
Inflation Reduction Act (1)
Influenza (50)
Intellectual property (135)
Interviews (84)
IPO (6946)
IRA (11)
Job creations (943)
Job search strategy (391)
JPM (19)
Kidney cancer (11)
Labor market (35)
Layoffs (185)
Leadership (14)
Legal (1563)
Liver cancer (45)
Longevity (8)
Lung cancer (419)
Lymphoma (261)
Machine learning (19)
Management (15)
Manufacturing (321)
MASH (115)
Medical device (4094)
Medtech (4119)
Mergers & acquisitions (5663)
Metabolic disorders (627)
Multiple sclerosis (128)
NASH (12)
Neurodegenerative disease (144)
Neuropsychiatric disorders (49)
Neuroscience (1565)
Neurotech (1)
NextGen: Class of 2026 (2085)
Non-profit (1400)
Now hiring (15)
Obesity (277)
Opinion (91)
Ovarian cancer (128)
Pain (101)
Pancreatic cancer (138)
Parkinson's disease (174)
Partnered (13)
Patents (228)
Patient recruitment (296)
Peanut (30)
People (18537)
Pharmaceutical (7)
Pharmacy benefit managers (4)
Phase 1 (13629)
Phase 2 (18568)
Phase 3 (12823)
Pipeline (3336)
Policy (66)
Postmarket research (1079)
Preclinical (5691)
Press Release (9)
Prostate cancer (137)
Psychedelics (19)
Radiopharmaceuticals (137)
Rare diseases (381)
Real estate (1507)
Recruiting (19)
Regulatory (10086)
Reports (38)
Research institute (1010)
Resumes & cover letters (69)
Rett syndrome (17)
RNA editing (6)
RSV (28)
Schizophrenia (104)
Series A (104)
Series B (74)
Service/supplier (2)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (19)
Startups (1173)
Stomach cancer (10)
Supply chain (40)
Tariffs (30)
The Weekly (11)
Vaccines (340)
Venture capital (48)
Weight loss (182)
Women's health (38)
Worklife (8)
Date
Last 7 days (264)
Last 30 days (1022)
Last 365 days (14885)
2026 (1354)
2025 (14958)
2024 (16787)
2023 (19042)
2022 (24376)
2021 (25671)
2020 (23228)
2019 (17405)
2018 (13202)
2017 (13231)
2016 (11592)
2015 (13596)
2014 (9288)
2013 (6779)
2012 (7063)
2011 (7479)
2010 (6581)
Location
Africa (196)
Alabama (29)
Alaska (2)
Arizona (61)
Arkansas (5)
Asia (17746)
Australia (3252)
California (5354)
Canada (1699)
China (628)
Colorado (220)
Connecticut (253)
Delaware (196)
Europe (39050)
Florida (830)
Georgia (166)
Hawaii (2)
Idaho (23)
Illinois (342)
India (29)
Indiana (242)
Iowa (11)
Japan (289)
Kansas (67)
Kentucky (18)
Louisiana (11)
Maine (15)
Maryland (620)
Massachusetts (3748)
Michigan (85)
Minnesota (282)
Mississippi (3)
Missouri (39)
Montana (17)
Nebraska (3)
Nevada (59)
New Hampshire (16)
New Jersey (1601)
New Mexico (8)
New York (1578)
North Carolina (631)
North Dakota (2)
Northern California (2704)
Ohio (98)
Oklahoma (5)
Oregon (19)
Pennsylvania (966)
Puerto Rico (6)
Rhode Island (13)
South America (314)
South Carolina (10)
Southern California (2074)
Tennessee (75)
Texas (815)
United States (18643)
Utah (112)
Vermont (1)
Virginia (96)
Washington D.C. (33)
Washington State (486)
West Virginia (2)
Wisconsin (25)
Wyoming (1)
261,646 Results for "active motif".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments
The partnership will allow BMS to advance a T cell–based therapy that is only activated once in the vicinity of a tumor.
January 22, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Battelle Awarded Contract Under Defense Microelectronics Activity’s Advanced Technology Support Program
January 14, 2026
·
2 min read
Press Releases
Motif Neurotech Wins UK Government Award to Develop Therapeutic Brain-Computer Interface
January 20, 2025
·
3 min read
Lone Star Bio
Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant Depression
Motif Neurotech announced today an oversubscribed Series A financing of $18.75 million led by Arboretum Ventures.
January 24, 2024
·
3 min read
Press Releases
Health Canada authorizes Gazyva® (obinutuzumab) for adults with active lupus nephritis
January 27, 2026
·
7 min read
Press Releases
TME Pharma provides update on its activities
January 5, 2026
·
7 min read
Press Releases
Immutep Quarterly Activities Report Q2 FY26
January 29, 2026
·
16 min read
Press Releases
iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete
Live Production Marketplace Now Available
February 6, 2026
·
5 min read
Press Releases
Amplia Therapeutics - Quarterly Activities and Cash Flow Reports - December 2025
February 1, 2026
·
7 min read
Press Releases
Formation Bio Licenses miR-124 Activator for Autoimmune Diseases from CTFH
January 30, 2026
·
3 min read
1 of 26,165
Next
